Hepatocyte Growth Factor and Lung Fibrosis
Proceedings of the American Thoracic Society · 15.07.2012 · 9 (3) · 158-163
DOI: 10.1513/pats.201202-018aw ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the American Thoracic Society, online erschienen am 15.07.2012. Verfasst von Bruno Crestani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Service de Pneumologie A, Hôpital Bichat, 46 rue Henri Huchard, Paris CEDEX 18, France. bruno.crestani@bch.aphp.fr. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 89 Literaturangaben.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis is currently believed to be driven by alveolar epithelial cells, with abnormally activated alveolar epithelial cells accumulating in an attempt to repair injured alveolar epithelium (1). Thus, targeting the alveolar epithelium to prevent or inhibit the development of pulmonary fibrosis might be an interesting therapeutic option in this disease. Hepatocyte growth factor (HGF) is a growth factor for epithelial and endothelial cells, which is secreted by different cell types, especially fibroblasts and neutrophils. HGF has mitogenic, motogenic, and morphogenic properties and exerts an antiapoptotic action on epithelial and endothelial cells. HGF has also proangiogenic effect. In vitro, HGF inhibits epithelial-to-mesenchymal cell transition and promotes myofibroblast apoptosis. In vivo, HGF has antifibrotic properties demonstrated in experimental models of lung, kidney, heart, skin, and liver fibrosis. Hence, the modulation of HGF may be an attractive target for the treatment of lung fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Service de Pneumologie A, Hôpital Bichat, 46 rue Henri Huchard, Paris CEDEX 18, France. bruno.crestani@bch.aphp.fr
Zitieren
APA
Crestani, B., Marchand-Adam, S., Quesnel, C., Plantier, L., Borensztajn, K., Marchal, J., Mailleux, A., Soler, P., & Dehoux, M. (2012). Hepatocyte Growth Factor and Lung Fibrosis. Proceedings of the American Thoracic Society, 9(3), 158-163. https://doi.org/10.1513/pats.201202-018aw
Vancouver
Crestani B, Marchand-Adam S, Quesnel C, Plantier L, Borensztajn K, Marchal J, et al. Hepatocyte Growth Factor and Lung Fibrosis. Proceedings of the American Thoracic Society. 2012;9(3):158-163. doi:10.1513/pats.201202-018aw
BibTeX
@article{Crestani2012,
author = {Crestani, Bruno and Marchand-Adam, Sylvain and Quesnel, Christophe and Plantier, Laurent and Borensztajn, Keren and Marchal, Joelle and Mailleux, Arnaud and Soler, Paul and Dehoux, Monique},
title = {Hepatocyte Growth Factor and Lung Fibrosis},
journal = {Proceedings of the American Thoracic Society},
year = {2012},
volume = {9},
number = {3},
pages = {158--163},
doi = {10.1513/pats.201202-018aw}
}
EUVIMED